Forum, in which we were able to count on excellent professionals of various profiles who shared their experiences with us on topics such as processes, risk assessment & monitoring, third parties’ management, challenges of the function, and trends in the short, medium and long term.
Two days in which there were connected professionals from many countries (even outside of Latam), who were able to enrich themselves with the dynamics of panels with discussion of current topics, and take lessons and tools for their day to day, considering the complex environment.
Who will
you meet?
Officers
General Counsels
Directors
Vice Presidents
From these areas:
- Ethics and Compliance
- Corporate Responsibility
- Quality Assurance
- International Contracts
- Regulatory Compliance
- Corporate Compliance
- Legal Affairs
- Internal Audit
- Business Conduct
- Transparency Operations
- Private practice Lawyers
Speaker Board
Irma Garcia Morales
Corporate Compliance Officer Mexico & LATAM
Natassia Ueno
Senior Attorney
Alejandro Torrendell
Regional General Counsel Latam
Lizandra Lima
Legal and Integrity Corporate Director
Sigfrido Rangel
Medical Director
Marcelo Nogueira
Global Director, Head of Ethics, Risk and Compliance Operations
Lorena Ivel Mauro
Global Regulatory Science Director-LATAM
Andres Vasquez Obando
Legal Compliance Director
Valentina Mainardi
General Manager
Elizabeth Rojas
CEO / GMPs, Audits & Regulatory Affairs
Alondra Diaz
Compliance VP
Renata Fidale
Executive Officer
Diogo Mota
Ethics and Compliance Associate Director
Santiago Cal y Mayor
Compliance Director
Pedro Fontenele Pereira
Financial Controls & Compliance Head
Mariana Fiordilino
Senior Legal & Compliance Director
Maria del Carmen Ruiz
Head of Legal & Compliance
Marcela Inzunza
Head of Legal Latam South Pacific
Joelson Santos
Lawyer & Corporate Governance Professional
Claudia Correa de Miranda
Regulatory Affairs Head | Regulatory Compliance
Carlos Lanardonne
Head of BD, Strategic Alliances & Est. Medicines, Novartis South Cone
Adriana Fussuma
Head of Ethics, Risk and Compliance
Fernando Fon
Director Medical and Regulatory Affairs
Program at a Glance
Compliance in Pandemic times
What has changed since the lockdown and mobilisation limitations
Risk profiling
Red flags all employees should be aware of
Regulatory Open Table
How can companies and regulatory agencies meet the requirements of both?
Challenges in the Interactions with Health Care Professionals
Clear communication between Pharma companies and Healthcare Professionals, key steps and agreements.
The new On-line methods
Telemedicine, webinars, quick-cards. Their regulations and implementations
Importance of an adequate implementation of SOP's
How, why and how often SOP’s should be updated
How to keep processes running in a sustainable way
Making sure the processes have a strong ground and are sustainable to mantain
Compliance trends in Latam
Which are going to be the next tendencies in the field